A murine model of Candida glabrata vaginitis

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 425-431

  Fidel Jr , Paul L ^a,b   Cutright, Jessica L ^a   Tait, Larry ^a   Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA GLABRATA; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; INFECTION RISK; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VAGINITIS;

EID: 0030052762     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.425     Document Type: Article

References (9)

1. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-90.
2. Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 1993;37:1962-5.
3. vanden Bossche H, Marichal P, Odds FC, Le-Jeune L, Coene MC. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992;36:2602-10.
4. Willocks L, Leen CL, Brettle RP, Urquhart D, Russell TB, Milne LJ. Fluconazole resistance in AIDS patients [letter]. J Antimicrob Chemother 1991:28:937-9.
5. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann NY Acad Sci 1988;544:547-57.
6. Centers for Disease Control. Non-reported sexually transmitted diseases. Morb Mortal Wkly Rep 1979;28:61.
7. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991;165:1168-75.
8. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981;24:407-38.
9. Odds FC. Candidosis of the genitalia. In: Odds FC, ed. Candida and candidosis. London: Bailliere Tindall, 1988:124-35.